7 Day Trial
ALL ACCESS PASS
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
NovoCure Price Chart Indicators
|Moving Averages||Level||Buy or Sell|
NovoCure Technical Analysis Indicators
|Chart Indicators||Level||Buy or Sell|
|MACD (12, 26):||0.11||Buy|
|Relative Strength Index (14 RSI):||52.53||Buy|
|Chaikin Money Flow:||812565||-|
|Bollinger Bands||Level||Buy or Sell|
|Bollinger Bands (25):||(69.72 - 78.94)||Buy|
|Bollinger Bands (100):||(71.29 - 82.77)||Sell|
NovoCure Technical Analysis
|Technical Analysis: Buy or Sell?|
|MACD (12, 26):|
|Relative Strength Index (14 RSI):|
|Bollinger Bands (25):|
|Bollinger Bands (100):|
Technical Analysis for NovoCure Stock
Is NovoCure Stock a Buy?
- NovoCure share price is 76.84 while NVCR 8-day simple moving average is 75.04, which is a Buy signal.
- The stock price of NVCR is 76.84 while NovoCure 20-day SMA is 75.44, which makes it a Buy.
- NovoCure 50-day simple moving average is 75.23 while NVCR share price is 76.84, making it a Buy technically.
- NVCR stock price is 76.84 and NovoCure 200-day simple moving average is 76.35, creating a Buy signal.
NVCR Technical Analysis vs Fundamental Analysis
NovoCure Stock Info
Price in USD:
NovoCure 52-Week Range
NovoCure (NVCR) is a Sell
NovoCure Share Price Forecast
What is the NovoCure stock price today?
The NovoCure stock price is 76.84 USD today.
Will NVCR stock go up or go down?
NovoCure> share price is forecast to RISE/FALL based on technical indicators
Is NovoCure overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure is overvalued.
Is NovoCure Stock a Buy?
- NovoCure share price is 76.84 while NVCR 8-day exponential moving average is 75.32, which is a Buy signal.
- The stock price of NVCR is 76.84 while NovoCure 20-day EMA is 75.34, which makes it a Buy.
- NovoCure 50-day exponential moving average is 75.75 while NVCR share price is 76.84, making it a Buy technically.
- NVCR stock price is 76.84 and NovoCure 200-day simple moving average is 81.25, creating a Sell signal.
Fundamental Analysis of NovoCure
Is NovoCure a good investment?
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.15 per share.
Technical Analysis of NovoCure
Should I short NovoCure stock?
- NVCR Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting NovoCure is a Buy
- NovoCure Relative Strength Index (RSI) is 52.53, which suggest NovoCure is overbought
- The Bollinger Bands (25) for NovoCure is (69.72 - 78.94), which suggest NovoCure is a Sell
- The Bollinger Bands (100) for NovoCure is (71.29 - 82.77), which suggest NovoCure is a Sell
* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.